A study comparing patients with these two etiologies highlighted a significantly higher frequency of TERT and CTNNB1 mutations in HCV-related HCC (53.6% and 26.4%, respectively) than in HBV-related (41.7% and 16.7%, respectively) [65]. Here, CTNNB1 is linked to hepatocellular carcinoma.